Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0H6QL
|
|||
Former ID |
DNC001266
|
|||
Drug Name |
Salicylhydroxamic acid
|
|||
Synonyms |
Salicylhydroxamic acid; N,2-Dihydroxybenzamide; 89-73-6; 2-Hydroxybenzohydroxamic acid; Salicylohydroxamic acid; SHAM; Salicylohydroximic acid; Benzamide, N,2-dihydroxy-; 2-Hydroxybenzhydroxamic acid; O-Hydroxybenzohydroxamic acid; SalicylhydroxaMicacid; SHA; 2,N-Dihydroxy-benzamide; NSC 5088; NSC 193440; Saliaylhydroxamic acid; UNII-8Q07182D0T; 2-hydroxybenzenecarbohydroxamic acid; Salicylic Hydroxamic Acid; EINECS 201-934-3; Salicylhydroxamic acid, 99%; MLS000069410; CHEMBL309339; CHEBI:45615; NSC5088
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C7H7NO3
|
|||
Canonical SMILES |
C1=CC=C(C(=C1)C(=O)NO)O
|
|||
InChI |
1S/C7H7NO3/c9-6-4-2-1-3-5(6)7(10)8-11/h1-4,9,11H,(H,8,10)
|
|||
InChIKey |
HBROZNQEVUILML-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 89-73-6
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
13518, 71250, 449466, 610582, 833668, 840695, 855524, 3134382, 5518185, 5782427, 7890461, 8190621, 14747933, 24899684, 26703870, 26717758, 43123332, 46507261, 47365511, 50045361, 50100829, 56370984, 56422153, 56465228, 57316199, 57410892, 58024016, 60758814, 75697192, 85089242, 85172718, 87575639, 87974377, 103275483, 103834529, 103926932, 104337076, 104668470, 109452842, 111677897, 117564931, 118048175, 118296601, 124800771, 124883284, 124883285, 125359409, 126660424, 126671624, 128037697
|
|||
ChEBI ID |
CHEBI:45615
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Plasmodium Dihydroorotate dehydrogenase (Malaria DHOdehase) | Target Info | Inhibitor | [1] |
KEGG Pathway | Pyrimidine metabolism | |||
Metabolic pathways | ||||
Pathwhiz Pathway | Pyrimidine Metabolism | |||
Reactome | Pyrimidine biosynthesis | |||
WikiPathways | Metabolism of nucleotides |
References | Top | |||
---|---|---|---|---|
REF 1 | Effects of atovaquone and other inhibitors on Pneumocystis carinii dihydroorotate dehydrogenase. Antimicrob Agents Chemother. 1995 Feb;39(2):325-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.